|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,104.70 INR | -0.11% |
|
+1.44% | +20.82% |
| 10/06 | Zydus Lifesciences Unit Secures Reduction in GST Tax Demands | MT |
| 03/06 | Zydus Lifesciences Receives USFDA Warning Letter for Baddi Facility | MT |
| Market Cap | 1,11200Cr 1.17TCr 1.01TCr 930.78Cr 871.25Cr 1.63TCr 1.66TCr 11TCr 4.29TCr 54TCr 4.39TCr 4.3TCr 1,87300Cr | P/E Ratio 2026 |
17.4x | P/E Ratio 2027 * | 26.1x |
|---|---|---|---|---|---|
| Enterprise Value | 1,10500Cr 1.16TCr 1TCr 925.48Cr 866.3Cr 1.62TCr 1.65TCr 11TCr 4.26TCr 54TCr 4.36TCr 4.27TCr 1,86300Cr | EV / Sales 2026 |
3.61x | EV / Sales 2027 * | 3.87x |
| Free-Float |
24.83% | Yield 2026 |
0.11% | Yield 2027 * | 0.6% |
Last Transcript: Zydus Lifesciences Limited
| 1 day | -0.11% | ||
| 1 week | +1.44% | ||
| Current month | +2.51% | ||
| 1 month | +17.62% | ||
| 3 months | +21.95% | ||
| 6 months | +18.89% | ||
| Current year | +20.82% |
| 1 week | 1,076.2 |  | 1,119.8 |
| 1 month | 987.85 | | 1,119.8 |
| Current year | 835.5 | | 1,119.8 |
| 1 year | 835.5 | | 1,119.8 |
| 3 years | 533.05 | | 1,324.3 |
| 5 years | 319 | | 1,324.3 |
| 10 years | 202 | | 1,324.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 46 | 27/11/2009 | |
| Director of Finance/CFO | 65 | - | |
| Director of Finance/CFO | 56 | 01/09/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 46 | 01/04/2007 | |
| Director/Board Member | 71 | 01/08/1997 | |
| Chairman | 73 | 05/10/2011 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.11% | +1.44% | +13.31% | +113.41% | 1.17TCr | |
| +0.75% | +1.43% | +7.10% | +82.95% | 4.56TCr | |
| -0.20% | -3.59% | +40.67% | +83.59% | 3.35TCr | |
| +0.44% | -0.85% | -7.69% | +41.56% | 1.18TCr | |
| +0.59% | +0.78% | +36.70% | +127.43% | 912.1Cr | |
| +2.40% | +0.08% | +18.35% | +44.00% | 716.41Cr | |
| -1.12% | -0.56% | +41.74% | -17.87% | 649.02Cr | |
| +1.37% | +0.35% | +30.18% | +234.95% | 645.39Cr | |
| +0.51% | -3.04% | -43.06% | -5.07% | 515.65Cr | |
| -0.39% | +5.19% | +18.86% | +113.20% | 411.38Cr | |
| Average | +0.42% | +0.45% | +15.62% | +81.81% | 1.41TCr | |
| Weighted average by Cap. | +0.40% | -0.14% | +17.99% | +83.04% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 26TCr 274.88Cr 237.41Cr 218.78Cr 204.78Cr 383.78Cr 389.72Cr 2.58TCr 1.01TCr 13TCr 1.03TCr 1.01TCr 44TCr | 31TCr 326.09Cr 281.64Cr 259.54Cr 242.94Cr 455.28Cr 462.33Cr 3.06TCr 1.19TCr 15TCr 1.22TCr 1.2TCr 52TCr |
| Net income | 4.66TCr 49Cr 42Cr 39Cr 37Cr 68Cr 69Cr 460.59Cr 179.58Cr 2.27TCr 183.94Cr 180.02Cr 7.85TCr | 4.25TCr 45Cr 39Cr 36Cr 33Cr 62Cr 63Cr 419.81Cr 163.68Cr 2.07TCr 167.65Cr 164.08Cr 7.16TCr |
| Net Debt | -632.45Cr -6.65Cr -5.75Cr -5.3Cr -4.96Cr -9.29Cr -9.43Cr -63Cr -24Cr -307.84Cr -25Cr -24Cr -1.07TCr | 8.87TCr 93Cr 81Cr 74Cr 70Cr 130.28Cr 132.3Cr 876.92Cr 341.9Cr 4.32TCr 350.2Cr 342.74Cr 15TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/26/12 | 1,104.70 ₹ | -0.11% | 8,72,151 |
| 11/26/11 | 1,105.90 ₹ | +0.69% | 7,28,343 |
| 10/26/10 | 1,098.30 ₹ | -0.66% | 5,98,159 |
| 09/26/09 | 1,105.60 ₹ | +1.66% | 12,99,872 |
| 08/26/08 | 1,087.60 ₹ | -0.13% | 8,30,212 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ZYDUSLIFE Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition